Currently out of the existing stock ratings of Kevin Strang, 2 are a BUY (100%).
Analyst Kevin Strang, currently employed at JEFFERIES,
Kevin Strang has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PRAX, Praxis Precision Medicines at 20-Aug-2026.
Analyst best performing recommendations are on PRAX (PRAXIS PRECISION MEDICINES).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2024
$568
$257.73 (83.07%)
$400
1 days ago
(15-Nov-2026)
Buy Since 17-Jun-2024
$1050
$739.73 (238.41%)
$800
1 days ago
(15-Nov-2026)
Sell Since 04-May-2025
$189
$-121.27 (-39.09%)
$162
7 days ago
(09-Nov-2026)
7/21 (33.33%)
$-148.59 (-44.01%)
91
Hold Since 01-Feb-2026
$343
$32.73 (10.55%)
$362
7 days ago
(09-Nov-2026)
4/4 (100%)
$5.41 (1.60%)
20
Buy Since 17-Jun-2026
$478
$167.73 (54.06%)
$462
7 days ago
(09-Nov-2026)
0/3 (0%)
$140.41 (41.59%)
Which stock is Kevin Strang most bullish on?
What Year was the first public recommendation made by Kevin Strang?